If you’re a regular here, you know that we’re strong proponents of alternative, natural cancer treatments.
There’s one treatment in particular, however, that hasn’t gotten it’s due – and for which the science has been actively suppressed.
That treatment? B17.
And, in particular, the compound laetrile, which has a stunning concentration of vitamin B17.
Laetrile is easily found, too – in apricot seeds. Apricot seeds, in fact, are both delicious and edible and loaded with a cancer-fighting agent, amygdalin.
Amygdalin is made up of glucose, benzaldehyde, and cyanide. Now, you probably already know that cyanide is toxic – and, in fact, is toxic to all cells.
Somehow, though, studies suggest laetrile is far more toxic to cancer cells than other cells. (And don’t forget – cancer, and conventional chemotherapy and/or radiation treatments, are also toxic.)
Of course, it’s natural to wonder why B17 isn’t regularly prescribed if it’s such an amazing, natural treatment.
As always, the answer comes back to money – namely that because it’s naturally available, pharmaceuticals can’t make money off it or patent it. As such, it’s far less attractive to their business.
That’s why the FDA and Big Pharma have spent the last 40 years suppressing it and the evidence for it.
Consider the example of Dr Kanematsu Suigura, who long worked at Memorial Sloan Kettering Cancer Center. In his research with laetrile, he found trememdously positive results – but then everything changed. By the mid 1970’s, any of his work that showed positive results was shut down, and colleagues began to characterize Sugiura as fraudulent.
Notes former colleague Ralph Moss, who stuck with Suigura: “The people on Sloan Kettering’s Board of Directors were a ‘Who’s Who’ of investors in petrochemical and other polluting industries. In other words, the hospital was being run by people who made their wealth by investing in the worst cancer-causing things on the planet.”